Yet previous researches about CTSB in gliomas mainly focused on GBM, mostly in vitro, and lacked of comprehensive large-sample clinical analysis, which are inadequate in reflecting the actual role of CTSB regarding the immune microenvironment and tumor heterogeneity of gliomas. The gene discussed is CTSB; the disease is central nervous system cancer.